Emre Yekedüz
@yekeduz_emre
MD, Medical Oncologist I Research Fellow @DanaFarber_GU @Harvard | @ASCO #IMG CoP Comm Team Member| Assoc. Faculty @OncoAlert | Alumni @AnkaraUni @Hacettepe1967
ID:2735430730
https://connects.catalyst.harvard.edu/Profiles/display/Person/218337 06-08-2014 19:37:17
4,3K Tweets
1,6K Followers
984 Following
Follow People
Pleased to host our Brigham and Women’s Radiation Oncology colleague Dr. Mutlay Sayan (@MutlaySayan) for this month's GU Seminar, covering management of localized prostate cancer and his recently-published research identifying which patients might benefit from whole-pelvic radiation therapy.
Trainee & Early Career Oncologists:
Sessions and networking events for #ASCO24 ASCO are here!!!⬇️
Plan in advanced and get a ☕️ at the new, larger location of the ASCOTECAG lounge! (Hall C)
society.asco.org/sites/new-www.…
Jacob J. Adashek, DO Fernando Diaz, MD Aakash Desai, MD, MPH
🔈Are NECTIN4 amplifications genomic predictors of EV responses? ✅NECTIN4 amp 96% BOR
Nonamp 32% (<.001)
✅92% risk reduction for death (<.001)
⁉️Perhaps FISH might suffice without validation
ASCO ASCOPost ESMO - Eur. Oncology OncoAlert Yüksel Ürün Niklas Klümper Emre Yekedüz
The OncoAlert🚨NEWSLETTER OUT
Covering May 2-8, 2024
REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…
✅ The Lancet Commission on #ProstateCancer
✅DESTINY-PanTumor01
✅Osimertinib+Local tx for brain🧠mets in EGFRm #NSCLC 🫁
✅ASCENT in Triple Negative…
⭐️ Great effort to increase visibility of IMG Oncologists ' works during the ASCO #ASCO24 📸✈️
✅ Don't forget to send your abstract title and presentation time 💻📍
OncoAlert Nazli Dizman Ziad Bakouny, MD, MSc Fatemeh Ardeshir, MD Zeynep Irem Ozay, MD Toni Choueiri, MD ASCOTECAG
🚀For our early-career attendees, the #TECLounge is a great entry point into the larger meeting itself—a place to meet others👥, get questions answered✍️, and take a moment to sit down and plan out your meeting experience.🗒️
Ana I. Velázquez Mañana, MD MSc (she/her/ella) Ramy Sedhom, MD Fernando Diaz, MD Jacob J. Adashek, DO
🚨With #ASCO2024 right around the corner, the #TECAG is thrilled to announce the 🌟NEW Trainee & Early Career Lounge‼️ 🌟 We have outgrown our previous location due to the overwhelming popularity of the #TECLounge . 🏆
Ana I. Velázquez Mañana, MD MSc (she/her/ella) Ramy Sedhom, MD Fernando Diaz, MD Jacob J. Adashek, DO
The translational analysis of the MITO END-3 trial in endometrial cancer out on Annals of Oncology
Reveals:
✅In MSI-H tumors 🧬 patients benefited from avelumab treatment, while those with microsatellite-stable (MSS) tumors exhibited varying responses based on specific…
Out on Nature Communications
The OXEL study, a phase II trial in patients with triple-negative #BreastCancer post-neoadjuvant therapy
➡️demonstrated:
✅Combination of nivolumab 🧪and capecitabine significantly increased 📈peripheral immunoscore compared to either agent alone…
The Lancet Commission highlights the urgent need to address the projected doubling of global #ProstateCancer cases by 2040
Doing so by:
✅Early diagnosis strategies
✅Equitable access to care
✅increased research focus on ethnic disparities and treatment distribution in LMICs…